189 related articles for article (PubMed ID: 32669522)
1. Malnutrition as an important risk factor for drug-induced liver injury in patients on anti-tubercular therapy: an experience from a tertiary care center in South India.
Ali N; Gupta N; Saravu K
Drug Discov Ther; 2020; 14(3):135-138. PubMed ID: 32669522
[TBL] [Abstract][Full Text] [Related]
2. Novel risk factors and early detection of anti tubercular treatment induced liver injury-Looking beyond American Thoracic Society Guidelines.
Latief M; Dar WR; Sofi N; Dar IA; Kasana B; Hussain M; Arshad F; Shah BA; Koul PA
Indian J Tuberc; 2017 Jan; 64(1):26-32. PubMed ID: 28166913
[TBL] [Abstract][Full Text] [Related]
3. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.
Tomich LG; Núñez M; Mendes-Correa MC
Ann Hepatol; 2015; 14(6):888-94. PubMed ID: 26436361
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India.
Saha A; Shanthi F X M; Winston A B; Das S; Kumar A; Michael JS; Balamugesh T
J Prim Care Community Health; 2016 Jul; 7(3):171-4. PubMed ID: 27056794
[TBL] [Abstract][Full Text] [Related]
6. Predicting antitubercular drug-induced liver injury and its outcome and introducing a novel scoring system.
Raj Mani SS; Iyyadurai R; Mishra AK; Manjunath K; Prasad J; Lakshmanan J; Yadav B; Reginald A; Jasmine S; Hansdak SG; Zachariah A
Int J Mycobacteriol; 2021; 10(2):116-121. PubMed ID: 34558461
[TBL] [Abstract][Full Text] [Related]
7. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
[TBL] [Abstract][Full Text] [Related]
8. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
[TBL] [Abstract][Full Text] [Related]
9. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
[TBL] [Abstract][Full Text] [Related]
11. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study.
Zhao H; Wang Y; Zhang T; Wang Q; Xie W
Med Sci Monit; 2020 Mar; 26():e920350. PubMed ID: 32145061
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.
Yimer G; Gry M; Amogne W; Makonnen E; Habtewold A; Petros Z; Aderaye G; Schuppe-Koistinen I; Lindquist L; Aklillu E
PLoS One; 2014; 9(4):e94271. PubMed ID: 24714066
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes among patients admitted to hospital with antiretroviral and/or antituberculosis drug-induced liver injury.
Mehta R; Ive P; Evans D; Menezes CN
S Afr Med J; 2021 Apr; 111(5):474-481. PubMed ID: 34852891
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study.
Subbalaxmi MVS; Soanker R; Lakshmi AV
Curr Drug Saf; 2020; 15(3):198-204. PubMed ID: 32589563
[TBL] [Abstract][Full Text] [Related]
15. Antituberculous drug-induced liver injury: current perspective.
Devarbhavi H
Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK.
Abbara A; Chitty S; Roe JK; Ghani R; Collin SM; Ritchie A; Kon OM; Dzvova J; Davidson H; Edwards TE; Hateley C; Routledge M; Buckley J; Davidson RN; John L
BMC Infect Dis; 2017 Mar; 17(1):231. PubMed ID: 28340562
[TBL] [Abstract][Full Text] [Related]
17. Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests.
Patterson B; Abbara A; Collin S; Henderson M; Shehata M; Gorgui-Naguib H; Lynn W; Kon OM; John L
J Infect; 2021 Feb; 82(2):240-244. PubMed ID: 33271167
[TBL] [Abstract][Full Text] [Related]
18. NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
Wattanapokayakit S; Mushiroda T; Yanai H; Wichukchinda N; Chuchottawon C; Nedsuwan S; Rojanawiwat A; Denjanta S; Kantima T; Wongyai J; Suwankesawong W; Rungapiromnan W; Kidkeukarun R; Bamrungram W; Chaiwong A; Suvichapanich S; Mahasirimongkol S; Tokunaga K
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1364-1369. PubMed ID: 27725049
[TBL] [Abstract][Full Text] [Related]
19. Viral hepatitis prevalence in patients with active and latent tuberculosis.
Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal metabolomics of human plasma reveal metabolic dynamics and predictive markers of antituberculosis drug-induced liver injury.
Li M; Zhang D; Yang Q; Zhao Z; Zhang C; Zhou Y; Bai Y; Chen L; Tang X; Liu C; Zhou J; Chen X; Ying B
Respir Res; 2024 Jun; 25(1):254. PubMed ID: 38907347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
